Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.
about
Addressing the current bottlenecks of metabolomics: Isotopic Ratio Outlier Analysis™, an isotopic-labeling technique for accurate biochemical profilingBiomarkers in diabetes: hemoglobin A1c, vascular and tissue markersBiomedical research, a tool to address the health issues that affect African populations.Application of metabolomics: Focus on the quantification of organic acids in healthy adultsPredictive properties of plasma amino acid profile for cardiovascular disease in patients with type 2 diabetes.Transcriptome interrogation of human myometrium identifies differentially expressed sense-antisense pairs of protein-coding and long non-coding RNA genes in spontaneous labor at term.Diabetes Associated Metabolomic Perturbations in NOD Mice.Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathyDrug delivery interfaces in the 21st century: from science fiction ideas to viable technologies.Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus.Introduction to personalized medicine in diabetes mellitus.Power of metabolomics in biomarker discovery and mining mechanisms of obesity.Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.Plasma and urine metabolic fingerprinting of type 1 diabetic children.Global and gene-specific DNA methylation in adult type 2 diabetic individuals: a protocol for a systematic review.A Pilot Study on Characteristics of Metabolomics and Lipidomics according to Sasang Constitution.The potential use of biomarkers in the prevention of Type 2 diabetesThe dentist-scientist career pathway in Africa: opportunities and obstaclesDiabetes - the Role of Metabolomics in the Discovery of New Mechanisms and Novel BiomarkersDynamic Metabolic Profiling of Urine From Type 2 Diabetic KK-Ay Mice Treated with Repaglinide by GC-MS
P2860
Q24606161-1E6C272A-3FD4-49E8-B8C3-6DDB7421DF8DQ26996480-E2DCB984-D75E-4855-8486-D56D51578878Q33589357-87B6853E-9C23-4A87-96EB-797ABFAC9FC2Q33783924-6156F987-BFB5-433B-841C-78CF4AC63078Q33817483-751D75B6-C2CF-4C90-BCE7-09FA8145E601Q34400892-E587B1A1-332D-43EC-BB0F-DBE74140461CQ35153961-9950DA40-61E6-435C-BBBE-D88A51CB98FFQ35595619-6FF1BBCA-0C24-4F6E-AE75-3F974F6A0738Q37283351-3E6DD72C-FE55-492A-A45A-16E16FB9D91DQ37357309-CF45E808-999F-47FA-9BA2-925C103BEEECQ37523745-213C8085-B8FE-4650-8221-82555DA678A9Q38070832-F6960E39-D4DD-4654-ABCD-80E126A8A484Q38445925-FF69BFC9-2B18-4676-98DC-4607693988EFQ48001275-B9ADD21E-753D-4394-B4B1-39AF07B521F0Q55446457-D43085ED-148A-4406-B3FD-9CD3A6605194Q55555551-C2750921-E02E-4875-8F92-210A131BE79CQ56988022-FE9CC7E2-AEAB-44E3-8275-DCEC724FAD2CQ57165198-B2182597-D8E0-4F39-9D4F-09EFDF2D40AAQ57797336-9458E800-7605-4E8B-8AC4-A42352F5496FQ58126703-2F8FF112-F63A-4CD0-8127-71849EDCDAB2
P2860
Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.
@ast
Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.
@en
type
label
Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.
@ast
Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.
@en
prefLabel
Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.
@ast
Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.
@en
P2860
P356
P1433
P1476
Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine
@en
P2093
Aine M McKillop
P2860
P304
P356
10.2337/DC11-0837
P407
P5008
P577
2011-12-01T00:00:00Z